Individual risk profiling for breast cancer recurrence: Towards tailored follow-up schemes

British Journal of Cancer

Volumn 109, Issue 4, 2013, Pages 866-871

  Kraeima, J ^a,b   Siesling, S ^a,c   Vliegen, I M H ^b   Klaase, J M ^d   Ijzerman, M J ^a  

^a UNIVERSITY OF TWENTE   (Netherlands)

^b Centre of Telecommunication and Information Technology (CTIT)   (Netherlands)

^c Department of Registration and Research   (Netherlands)

^d MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER PROGNOSIS; CANCER RECURRENCE; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR VOLUME;

AGE FACTORS; BIOLOGICAL MARKERS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, MULTIPLE PRIMARY; ODDS RATIO; PROGNOSIS; RADIOTHERAPY, ADJUVANT; REGISTRIES; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TUMOR BURDEN;

EID: 84883195448     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.401     Document Type: Article

References (29)

1. Abi-Raad R., Boutrus R, Wang R, Niemierko A, Macdonald S, Smith B, Taghian G (2011) Patterns and risk factors of locoregional recurrence in T1-T2 node negative breast cancer patients treated with mastectomy: implications for postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys 81(3): e151-e157.
2. Aebi S, Davidson T, Gruber G, Castoglione M (2011) Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 22(suppl 6): vi12-vi24.
3. Bantema-Joppe EJ, de Munck L, Visser O, Willemse P, Langendijk J, Siesling S, Maduro J (2011) Early-stage young breast cancer patients: impact of local treatment on survival. Int J Radiat Oncol Biol Phys 81(4): e553-e559.
4. Campbell H, Gray A, Harris A, Briggs A, Taylor M (2010) Estimation and external validation of a new prognostic model for predicting recurrencefree survival for early breast cancer patients in the UK. Br J Cancer 103(6): 776-786.
5. Cardoso F, Harbeck N, Fallowfield L, Kyriakides S, Senkus E (2012) Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(suppl 7): vii11-vii19.
6. Collins R, Bekker HL, Dodwell DJ (2004) Follow-up care of patients treated for breast cancer: a structured review. Cancer Treat Rev 30(1): 19-35.
7. Comprehensive Cancer Centers, the Netherlands (2011) Dataset Breast Cancer from http://www.cijfersoverkanker.nl/selecties/Dataset-1/ img4f3ba09dec237. Retrieved on 9 December 2012.
8. GIVIO Investigators (1994) Impact of follow-up testing on survival and health-related quality of live in breast cancer patients. JAMA 271: 20.
9. Grunfeld E (2005) Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update). CMAJ 172(10): 1319-1320.
10. Health Council of the Netherlands (2007) Follow-up in oncology: 154.
11. Kimman ML, Voogd AC, Dirksen CD, Falger P, Hupperets P, Keymeulen K, Hebly M, Dehing C, Lambin P, Boersma LJ (2007) Follow-up after curative treatment for breast cancer: why do we still adhere to frequent outpatient clinic visits? Eur J Cancer 43(4): 647-653.
12. Kimman ML, Dirksen CD, Voogd AC, Falger P, Gijsen BCM, Thuring M, Lenssen A, van der Ent F, Verkeyn J, Haekens C, Hupperets P, Nuytinck JKS, van Riet Y, Brenninkmeijer SJ, Scheijmans LJEE, Kessels A, Lambin P, Boersma LJ (2011) Economic evaluation of four follow-up strategies after curative treatment for breast cancer: results of an RCT. Eur J Cancer 47(8): 1175-1185.
13. Kolb TM, Lichy J, Newhouse JH (2002) Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 225(1): 165-175.
14. Komoike Y, Akiyama F, Ilno Y, Ikeda T, Tanaka S, Ohsumi S, Kusama M, Sano M, Shin E, Seumasu K, Sonoo H, Taguchi T, Nishi T, Nishmura R, Haga S, Mise K, Kinoshita T, Murakami S, Yoshimoto M, Tsukama H, Inaij H (2006) Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer. Cancer 106(1): 35-41.
15. Kriege M, Brekelmans CTM, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM, Manoliu RA, Kok T, Peterse H, Linthorst MMA, Muller SH, Meijer S, Oosterwijk JC, Beex LVAM, Tollenaar RAEM, de Koning HJ, Rutgers EJT, Klijn JGM (2004) Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351(5): 427-437.
16. Levac D, Colquhoun H, O'Brien KK (2010) Scoping studies: advancing the methodology. Implement Sci 5(1): 69.
17. Litière S, Werutsky G, Fentiman IS, Rutgers E, Christiaens MR, van Limbergen E, Baaijens MH, Bogaerts J, Bartelink H (2012) Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol 13(4): 412-419.
18. Montgomery DA, Krupa K, JackWJL, Kerr GR, Kunkler IH, Thomas J, Dixon JM (2007) Changing pattern of the detection of locoregional relapse in breast cancer: the Edinburgh experience. Br J Cancer 96(12): 1802-1807.
19. NABON (2012) Guideline Breast Cancer (Richtlijn Mammacarcinoom) pg.199. National Institute for Health and Clinical Excellence (2002) Guidance on cancer service: improved outcomes in breast cancer care. Manual update , from http://guidance.nice.org.uk/CSGBC/Guidance/pdf/English.
20. Palli D, Russo A, Saieva RAC, Ciatto S, Rosselli Del Turco M, Distante V, Pacini P (1999) Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. JAMA 281(17): 1586-1586.
21. Rojas MPMP, Telaro E, Moschetti I, Coe L, Fossati R, Liberati A, Rosselli MDT (2000) Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev (4): Art. No: CD001768. doi: 10.1002/14651858. CD001768.pub2.
22. Rumrill PD, Fitzgerald SM, Merchant WR (2010) Using scoping literature reviews as a means of understanding and interpreting existing literature. Work 35(3): 399-404.
23. Sangen MC, Wiel FM, Poortmans PM, Tjan-Heijnen VC, Nieuwenhuijzen G, Roumen RM, Ernst M, Tutein Nothenius-Puylaert M, Voogd AC (2011) Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged r40 years. Breast Cancer Res Treat 127(1): 207-215.
24. Sanghani M, Balk E, Cady B, Wazer D (2007) Predicting the risk of local recurrence in patients with breast cancer. Am J Clin Oncol 30(5): 473-480.
25. Sanghani M, Truong PT, Abi Raad R, Niemierko A, Lesperance M, Olivotto IA, Wazer DE, Taghain AG (2010) Validation of a web-based predictive nomogram for ipsilateral breast tumor recurrence after breast conserving therapy. J Clin Oncol 28(5): 718-722.
26. van der Hage J, Putter H, Bonnema J, Bartelink H, Therasse P, van de Velde CJH (2003) Impact of locoregional treatment on the early-stage breast cancer patients: a retrospective analysis. Eur J Cancer 39(15): 2192-2199.
27. van Tienhoven G, Voogd AC, Peterse JL, Nielsen M, Andersen K, Mignolet F, Sylvester R, Fentiman IS, van der Schueren E, van Zijl K, Blichert-Toft M, Bartelink H, van Dongen JA (1999) Prognosis after treatment for locoregional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). Eur J Cancer 35(1): 32-38.
28. Werkhoven E, Hart G, Tinteren H, Elkhuizen P, Collette L, Poortmans P, Bartelink H (2011) Nomogram to predict ipsilateral breast relapse based on pathology review from the EORTC 22881-10882 boost versus no boost trial. Radiother Oncol 100(1): 101-107.
29. Zumsteg Z, Morrow M, Arnols B, Zheng J, Zhang Z, Robsons M, Traina T, McCornmick B, Powell S, Ho A (2013) Breast-conserving therapy achieves locoregional outcomes comparable to mastectomy in women with T1-2N0 triple-negative breast cancer. Ann Surg Oncol; e-pub ahead of print 19 May 2013; doi:10.1245/s10434-013-3011-9.